Literature DB >> 9005945

High level production of soluble single chain antibodies in small-scale Escherichia coli cultures.

S M Kipriyanov1, G Moldenhauer, M Little.   

Abstract

We have investigated the effect of growth and induction conditions on the production of soluble single-chain Fv antibody fragments in Escherichia coli under the control of wt lac promoter. The scFv was directed into the periplasmic space by a pelB leader sequence. Addition of sucrose to the medium gave a 15-25-fold increase in the yield of soluble scFv-phOx (3.0 mg/l) for bacterial shake-tube cultures and an increase of 80-150-fold (16.5 mg/l) for shake-flask cultures. Using flask culture in the presence of 0.4 M sucrose, a significant amount of scFv was released into the medium. We found that the scFv could be made to accumulate in the periplasm or be secreted into the medium by simply changing the incubation conditions and the concentration of the inducer. The ratio between soluble antibody fragments and insoluble scFv aggregates proved to be dependent on the strength of the promoter. Lowering the incubation temperature below 20 degrees C had no effect on the yield of soluble antibody fragments in the periplasm, but they were no longer secreted into the medium. An example of high level production in shake-flask cultures and one-step purification by immobilized metal affinity chromatography (IMAC) is described for a soluble scFv specific for the T cell surface antigen CD3. The biological activity of the purified anti-CD3 scFv was demonstrated by flow cytometry. This method should be especially useful for the functional screening of a large number of clones in small-scale cultures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9005945     DOI: 10.1016/s0022-1759(96)00188-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  42 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  Enhanced phagocytosis of Candida species mediated by opsonization with a recombinant human antibody single-chain variable fragment.

Authors:  Melanie Wellington; Joseph M Bliss; Constantine G Haidaris
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 3.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

Review 4.  The production and application of single-chain antibody fragments.

Authors:  D Blazek; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

5.  Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.

Authors:  Andreas Lehmann; Josephine H F Wixted; Maxim V Shapovalov; Heinrich Roder; Roland L Dunbrack; Matthew K Robinson
Journal:  MAbs       Date:  2015-09-04       Impact factor: 5.857

6.  Construction of human naïve Fab library and characterization of anti-met Fab fragment generated from the library.

Authors:  Yongjun Jiao; Ping Zhao; Jin Zhu; Tessa Grabinski; Zhengqing Feng; Xiaohong Guan; R Scot Skinner; Milton D Gross; Rick V Hay; Hiroshi Tachibana; Brian Cao
Journal:  Mol Biotechnol       Date:  2005-09       Impact factor: 2.695

Review 7.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

8.  Broad-host-range plasmid pJB658 can be used for industrial-level production of a secreted host-toxic single-chain antibody fragment in Escherichia coli.

Authors:  H Sletta; A Nedal; T E V Aune; H Hellebust; S Hakvåg; R Aune; T E Ellingsen; S Valla; T Brautaset
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

9.  Biotin carboxyl carrier protein co-purifies as a contaminant in core-streptavidin preparations.

Authors:  Welson Wen-Shang Wang; Dipankar Das; Mavanur R Suresh
Journal:  Mol Biotechnol       Date:  2005-09       Impact factor: 2.695

10.  Inhibition of Candida albicans adhesion by recombinant human antibody single-chain variable fragment specific for Als3p.

Authors:  Sonia S Laforce-Nesbitt; Mark A Sullivan; Lois L Hoyer; Joseph M Bliss
Journal:  FEMS Immunol Med Microbiol       Date:  2008-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.